|FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma|
L Sehgal, R Mathur, FK Braun, JF Wise, Z Berkova, S Neelapu, LW Kwak, ...
Leukemia 28 (12), 2376-2387, 2014
|Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome|
FCM Braun, P Grabarczyk, M Möbs, FK Braun, J Eberle, M Beyer, ...
Leukemia 25 (9), 1494-1501, 2011
|Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex|
JF Wise, Z Berkova, R Mathur, H Zhu, FK Braun, RH Tao, AL Sabichi, ...
Blood, The Journal of the American Society of Hematology 121 (23), 4729-4739, 2013
|Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells|
FK Braun, LF Fecker, C Schwarz, P Walden, C Assaf, H Dürkop, W Sterry, ...
Journal of investigative dermatology 127 (10), 2425-2437, 2007
|Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma|
A Busse, AM Asemissen, A Nonnenmacher, F Braun, S Ochsenreither, ...
European Journal of Cancer 47 (5), 690-696, 2011
|Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac/hyaluronic acid correlates with downregulation of c-FLIP|
LF Fecker, E Stockfleth, FK Braun, PM Rodust, C Schwarz, A Köhler, ...
Journal of investigative dermatology 130 (8), 2098-2109, 2010
|Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling|
N Al-Yacoub, LF Fecker, M Möbs, M Plötz, FK Braun, W Sterry, J Eberle
Journal of investigative dermatology 132 (9), 2263-2274, 2012
|Thyroid hormones and changes in body weight and metabolic parameters in response to weight loss diets: the POUNDS LOST trial|
G Liu, L Liang, GA Bray, L Qi, FB Hu, J Rood, FM Sacks, Q Sun
International journal of obesity 41 (6), 878-886, 2017
|Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand|
FK Braun, N Al-Yacoub, M Plötz, M Möbs, W Sterry, J Eberle
Journal of investigative dermatology 132 (2), 429-439, 2012
|Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP|
FK Braun, B Hirsch, N Al-Yacoub, H Dürkop, C Assaf, ME Kadin, W Sterry, ...
Journal of investigative dermatology 130 (3), 826-840, 2010
|Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design|
JL Rokita, KS Rathi, MF Cardenas, KA Upton, J Jayaseelan, KL Cross, ...
Cell reports 29 (6), 1675-1689. e9, 2019
|Systems biology–based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma|
L Huang, SG Injac, K Cui, F Braun, Q Lin, Y Du, H Zhang, M Kogiso, ...
Science translational medicine 10 (464), 2018
|Targeting Wnt pathway in mantle cell lymphoma-initiating cells|
R Mathur, L Sehgal, FK Braun, Z Berkova, J Romaguerra, M Wang, ...
Journal of hematology & oncology 8 (1), 1-12, 2015
|Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sezary syndrome|
GK Przybylski, C Gand, FC Braun, P Grabarczyk, AW Kuss, K Olek-Hrab, ...
Oncotarget 8 (24), 39627, 2017
|Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis|
FK Braun, R Mathur, L Sehgal, R Wilkie-Grantham, J Chandra, Z Berkova, ...
PloS one 10 (3), e0117994, 2015
|HMGB1 Promotes Mitochondrial Dysfunction–Triggered Striatal Neurodegeneration via Autophagy and Apoptosis Activation|
L Qi, X Sun, FE Li, BS Zhu, FK Braun, ZQ Liu, JL Tang, C Wu, F Xu, ...
PLoS One 10 (11), e0142901, 2015
|Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells|
A Busse, AM Asemissen, A Nonnenmacher, S Ochsenreither, A Fusi, ...
Journal of Immunotherapy 34 (1), 113-119, 2011
|Targeting nucleolin for better survival in diffuse large B-cell lymphoma|
N Jain, H Zhu, T Khashab, Q Ye, B George, R Mathur, RK Singh, ...
Leukemia 32 (3), 663-674, 2018
|90Y‐ibritumomab tiuxetan radiotherapy as first‐line therapy for early stage low‐grade B‐cell lymphomas, including bulky disease|
F Samaniego, Z Berkova, JE Romaguera, N Fowler, MA Fanale, B Pro, ...
British journal of haematology 167 (2), 207-213, 2014
|Concurrent inhibition of neurosphere and monolayer cells of pediatric glioblastoma by Aurora A Inhibitor MLN8237 predicted survival extension in PDOX models|
M Kogiso, L Qi, FK Braun, SG Injac, L Zhang, Y Du, H Zhang, FY Lin, ...
Clinical Cancer Research 24 (9), 2159-2170, 2018